| Bioactivity | 4-Aminobenzohydrazide is an irreversible MPO myeloperoxidase inhibitor with an IC50 of 0.3 µM[1]. It is used for the research of subacute stroke[2]. |
| Name | 4-Aminobenzohydrazide |
| CAS | 5351-17-7 |
| Formula | C7H9N3O |
| Molar Mass | 151.17 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Kettle AJ, et al. Inhibition of myeloperoxidase by benzoic acid hydrazides. Biochem J. 1995 Jun 1;308 ( Pt 2)(Pt 2):559-63. [2]. Forghani R, et al. Myeloperoxidase propagates damage and is a potential therapeutic target for subacute stroke. J Cereb Blood Flow Metab. 2015 Mar;35(3):485-93. |
4-Aminobenzohydrazide
CAS: 5351-17-7 F: C7H9N3O W: 151.17
4-Aminobenzohydrazide is an irreversible MPO myeloperoxidase inhibitor with an IC50 of 0.3 µM. It is used for the resea
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.